Diabetes Clinical Trials in San Jose, CA

71 recruiting studies within 50 miles

Phase

Trial	Phase	Sponsor	Dist.
SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes	Phase 2	SAb Biotherapeutics, Inc.	<1 mi
Safer Aging With Diabetes Monitoring	N/A	Kaiser Permanente	<1 mi
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)	Phase 2/3	CSL Behring	<1 mi
Surabgene Lomparvovec Administered in the Suprachoroidal Space in Adult Participants With Diabetic Retinopathy Without Center-Involved Diabetic Macular Edema	Phase 2/3	AbbVie	11 mi
A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma	Phase 2	Children's Oncology Group	16 mi
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events	N/A	Cleerly, Inc.	16 mi
A Study to Evaluate the Efficacy and Safety of Orally Administered VX-01	Phase 2	Vantage Biosciences Ltd	16 mi
Diabetes-Centered Evaluation of Revascularization Strategy of Functional and Imaging-CombiNEd State-of-the-Art Percutaneous Coronary Intervention or Coronary-Artery Bypass Grafting in Patients With Diabetes Mellitus and Multivessel Coronary Artery Disease	N/A	Duk-Woo Park, MD	16 mi
Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes	Phase 4	VA Office of Research and Development	16 mi
Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM)	—	Jaeb Center for Health Research	16 mi
Transformative Research in Diabetic Nephropathy	—	University of Pennsylvania	16 mi
CHIME: Comparing Health Interventions for Maternal Equity	N/A	Stanford University	16 mi
Food Insecurity Reduction & Strategy Team	N/A	Stanford University	16 mi
Normal-weight Diabetes: Adipocyte-directed Therapy With Pioglitazone or Tirzepatide	Phase 4	Stanford University	16 mi
Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease	Phase 3	Alessandro Doria	17 mi
Post Prandial Individual Responses to Different Foods	N/A	Stanford University	17 mi
TrialNet Pathway to Prevention of T1D	—	University of South Florida	17 mi
Longitudinal Multi-Omic Profiles to Reveal Mechanisms of Obesity-Mediated Insulin Resistance	N/A	Stanford University	17 mi
Diabetes RElated to Acute Pancreatitis and Its Mechanisms	—	Milton S. Hershey Medical Center	17 mi
SPYRAL GEMINI Pilot Study	N/A	Medtronic Vascular	17 mi
Diabetes RElated to Acute Pancreatitis and Its Mechanisms: Metabolic Outcomes Using Novel CGM Metrics	—	Milton S. Hershey Medical Center	17 mi
Using Continuous Glucose Monitoring to Quantify the Effects of NOURISH's Culturally Modified Meals on Asian Americans With Type 2 Diabetes	N/A	Stanford University	17 mi
North American Mitochondrial Disease Consortium Patient Registry and Biorepository (NAMDC)	—	Columbia University	17 mi
Implementing Scalable, PAtient-centered, Team-based, Technology-enabled Care for Adults With Type 2 Diabetes (iPATH)	N/A	Stanford University	17 mi
Type 1 Diabetes Extension Study	—	National Institute of Allergy and Infectious Diseases (NIAID)	17 mi
A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes	Phase 2	Zucara Therapeutics Inc.	24 mi
Trial to Evaluate the Safety and Effectiveness of Treatment With COMS One Device in Subjects With Diabetic Foot Ulcers	N/A	Piomic Medical	27 mi
A Clinical Investigation to Follow the Progress of Exuding Chronic Wounds Using Mepilex® Up as the Primary Dressing.	N/A	Molnlycke Health Care AB	27 mi
A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease	Phase 2	Novo Nordisk A/S	31 mi
Precision Dosing of Metformin in Youth With T2D	Early 1	University of California, San Francisco	39 mi
CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)	Phase 1/2	COUR Pharmaceutical Development Company, Inc.	41 mi
Accuracy and Precision of the Continuous Glucose Monitoring System 'CareSens Air 3' in Adult Patients With T1DM	N/A	i-SENS, Inc.	41 mi
Dementia and Diabetes Prevention Program	N/A	University of California, Davis	41 mi
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes	Phase 3	Eli Lilly and Company	41 mi
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes	Phase 3	Hoffmann-La Roche	41 mi
AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight	Phase 3	Novo Nordisk A/S	41 mi
A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus	Phase 2	Corxel Pharmaceuticals	41 mi
ROME GS System Study	N/A	Senseonics, Inc.	41 mi
Pharmacokinetic and Early Efficacy of OPT101 in Patients With Type 1 Diabetes Mellitus	Phase 2	Op-T LLC	41 mi
A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight	Phase 3	Novo Nordisk A/S	41 mi
A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes	Phase 2	Novo Nordisk A/S	41 mi
A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight	Phase 2	Eli Lilly and Company	41 mi
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Alone or in Combination With Dapagliflozin Compared With Placebo in Adults With Type 2 Diabetes Mellitus	Phase 3	AstraZeneca	41 mi
A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity	Phase 3	Pfizer	41 mi
A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar	Phase 3	Boehringer Ingelheim	41 mi
Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes	Phase 2	Regeneron Pharmaceuticals	41 mi
A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus	Phase 3	AstraZeneca	41 mi
Automated Insulin for Management of Intrapartum Glycemia	N/A	University of California, San Francisco	42 mi
Inflammation, Diabetes, Ethnicity and Obesity Cohort	—	University of California, San Francisco	42 mi
DECIDE: A Comparative Effectiveness Trial of Metformin Versus Insulin for the Treatment of Gestational Diabetes	Phase 4	Ohio State University	42 mi
Commercial or Open Source Closed Loop Impact on Pregnancy Study	—	University of California, San Francisco	42 mi
A Longitudinal, Observational Study Comparing Real-World Experiences of Teplizumab-Treated and Untreated Participants With Stage 2 Type 1 Diabetes in the United States	—	Sanofi	42 mi
INHALE-1st: Afrezza® For Youth With Newly-Diagnosed Type 1 Diabetes	Phase 2	Mannkind Corporation	42 mi
CAlcium and VAsopressin Following Injury Early Resuscitation (CAVALIER) Trial	Phase 2	Jason Sperry	42 mi
Registry for Stage 2 Type 1 Diabetes	—	Sanofi	42 mi
Efficacy of KL1333 in Adult Patients With Primary Mitochondrial Disease	Phase 2	Pharming Technologies B.V.	42 mi
A Study of GNTI-122 in Adults Recently Diagnosed With T1D	Phase 1	GentiBio, Inc	42 mi
HLA Demographics Study in Adults With Type 1 Diabetes	—	GentiBio, Inc	42 mi
Village-Integrated Eye Worker Trial II	N/A	University of California, San Francisco	42 mi
A Safety, Tolerability, and Efficacy Study of VX-880 and VX-017 in Participants With Type 1 Diabetes	Phase 3	Vertex Pharmaceuticals Incorporated	42 mi
Implementation of Team Clinic for Type 2 Diabetes (TCT2)	N/A	Children's Hospital Los Angeles	42 mi
A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes	Phase 3	Sanofi	42 mi
DFC 004 Biomarkers for Active Diabetic Foot Ulcers	—	University of Michigan	42 mi
A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)	Phase 3	Eli Lilly and Company	42 mi
Achieving Chronic Care equiTy by leVeraging the Telehealth Ecosystem	N/A	University of California, San Francisco	42 mi
A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New Onset Type 1 Diabetes	Phase 1/2	City of Hope Medical Center	42 mi
Rezpegaldesleukin (NKTR-358) in New Onset Type 1 Diabetes Mellitus	Phase 2	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)	42 mi
Strategies for Improving Linkage-to-Care After Eye Disease Screening	N/A	University of California, San Francisco	42 mi
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease	Phase 3	Boehringer Ingelheim	45 mi
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin	Phase 3	AstraZeneca	45 mi
Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease	Phase 2	Regeneron Pharmaceuticals	47 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.